Product Code: ETC5634667 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The cardiac marker testing market in Bosnia and Herzegovina is developing as healthcare facilities increasingly adopt diagnostic tests for cardiovascular diseases. The market is driven by the rising prevalence of heart diseases and advancements in testing technologies. However, challenges such as the high cost of tests and limited access to advanced healthcare facilities in some regions could hinder market growth.
The cardiac marker testing market in Bosnia and Herzegovina is driven by the rising prevalence of cardiovascular diseases, which necessitates early diagnosis and monitoring. The increasing adoption of point-of-care testing and the growing awareness about the importance of timely diagnosis in preventing heart-related complications also support market growth. Additionally, advancements in testing technologies and the expansion of healthcare infrastructure contribute to the markets expansion.
The cardiac marker testing market in Bosnia and Herzegovina faces challenges due to limited healthcare infrastructure and awareness. Access to advanced diagnostic tools like cardiac marker tests is restricted in many parts of the country due to the uneven distribution of healthcare facilities and resources. Additionally, the lack of widespread awareness among both healthcare providers and patients about the benefits of early cardiac testing further constrains market growth.
The cardiac marker testing market in Bosnia and Herzegovina is influenced by healthcare policies aimed at improving diagnostic capabilities and patient outcomes. The government invests in healthcare infrastructure and provides funding for advanced diagnostic technologies, including cardiac marker testing. Policies that ensure the accessibility and affordability of medical tests also support the growth of this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bosnia and Herzegovina Cardiac Marker Testing Market Overview |
3.1 Bosnia and Herzegovina Country Macro Economic Indicators |
3.2 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Bosnia and Herzegovina Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Bosnia and Herzegovina Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Bosnia and Herzegovina Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bosnia and Herzegovina Cardiac Marker Testing Market Trends |
6 Bosnia and Herzegovina Cardiac Marker Testing Market Segmentations |
6.1 Bosnia and Herzegovina Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.3 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Bosnia and Herzegovina Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Bosnia and Herzegovina Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Bosnia and Herzegovina Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Bosnia and Herzegovina Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Bosnia and Herzegovina Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Bosnia and Herzegovina Cardiac Marker Testing Market Export to Major Countries |
7.2 Bosnia and Herzegovina Cardiac Marker Testing Market Imports from Major Countries |
8 Bosnia and Herzegovina Cardiac Marker Testing Market Key Performance Indicators |
9 Bosnia and Herzegovina Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Bosnia and Herzegovina Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Bosnia and Herzegovina Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Bosnia and Herzegovina Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Bosnia and Herzegovina Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Bosnia and Herzegovina Cardiac Marker Testing Market - Competitive Landscape |
10.1 Bosnia and Herzegovina Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Bosnia and Herzegovina Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |